These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8448269)

  • 1. Variation in symptom severity over the menstrual cycle of schizophrenics.
    Hallonquist JD; Seeman MV; Lang M; Rector NA
    Biol Psychiatry; 1993 Feb; 33(3):207-9. PubMed ID: 8448269
    [No Abstract]   [Full Text] [Related]  

  • 2. [Do estrogens have an antipsychotic action?].
    Riecher-Rössler A; Häfner H; Stumbaum M; Schmidt R
    Fortschr Neurol Psychiatr; 1994 Jan; 62(1):22-8. PubMed ID: 8144127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of estrogens in schizophrenia gender differences.
    Seeman MV; Lang M
    Schizophr Bull; 1990; 16(2):185-94. PubMed ID: 2197713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence for a specific role of estradiol in schizophrenia?
    Riecher-Rössler A; Häfner H; Dütsch-Strobel A; Oster M; Stumbaum M; van Gülick-Bailer M; Löffler W
    Biol Psychiatry; 1994 Oct; 36(7):492-4. PubMed ID: 7811850
    [No Abstract]   [Full Text] [Related]  

  • 5. Menstrually related symptom changes in women with schizophrenia.
    Harris AH
    Schizophr Res; 1997 Oct; 27(1):93-9. PubMed ID: 9373899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the menstrual cycle phase on the therapeutic response in schizophrenia.
    Gattaz WF; Vogel P; Riecher-Rössler A; Soddu G
    Biol Psychiatry; 1994 Jul; 36(2):137-9. PubMed ID: 7948447
    [No Abstract]   [Full Text] [Related]  

  • 7. Change of symptoms of schizophrenia across phases of menstrual cycle.
    Ray P; Mandal N; Sinha VK
    Arch Womens Ment Health; 2020 Feb; 23(1):113-122. PubMed ID: 30798377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can estradiol modulate schizophrenic symptomatology?
    Riecher-Rössler A; Häfner H; Stumbaum M; Maurer K; Schmidt R
    Schizophr Bull; 1994; 20(1):203-14. PubMed ID: 8197416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia.
    Bergemann N; Parzer P; Runnebaum B; Resch F; Mundt C
    Psychol Med; 2007 Oct; 37(10):1427-36. PubMed ID: 17451629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinister psychotics. Left-handedness in schizophrenia and affective disorder.
    Taylor MA; Amir N
    J Nerv Ment Dis; 1995 Jan; 183(1):3-9. PubMed ID: 7807066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P3 in schizophrenia is affected by stimulus modality, response requirements, medication status, and negative symptoms.
    Pfefferbaum A; Ford JM; White PM; Roth WT
    Arch Gen Psychiatry; 1989 Nov; 46(11):1035-44. PubMed ID: 2573328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia and oestrogens--is there an association?
    Riecher-Rössler A; Häfner H
    Eur Arch Psychiatry Clin Neurosci; 1993; 242(6):323-8. PubMed ID: 8323981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence.
    Grillon C; Courchesne E; Ameli R; Geyer MA; Braff DL
    Arch Gen Psychiatry; 1990 Feb; 47(2):171-9. PubMed ID: 2302027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics.
    Kathmann N; Wagner M; Rendtorff N; Engel RR
    Biol Psychiatry; 1995 May; 37(10):754-7. PubMed ID: 7640331
    [No Abstract]   [Full Text] [Related]  

  • 15. Symptom dimensions of schizophrenia: a selective integration of neurophysiological and neuropsychological correlates.
    Aderibigbe YA; Gureje O
    Neuropsychobiology; 1996; 34(4):192-200. PubMed ID: 9121620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia.
    Kanof PD; Davidson M; Johns CA; Mohs RC; Davis KL
    Am J Psychiatry; 1987 Dec; 144(12):1556-60. PubMed ID: 2825548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the Kraepelinean dichotomy.
    Wexler BE
    Biol Psychiatry; 1992 Mar; 31(6):539-41. PubMed ID: 1581434
    [No Abstract]   [Full Text] [Related]  

  • 18. [Illness theory and identity of psychiatry].
    Gaebel W
    Nervenarzt; 2001 May; 72(5):329-30. PubMed ID: 11386142
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM; O'Keane V; Murray RM
    Br J Psychiatry; 1996 Jan; 168(1):57-60. PubMed ID: 8770429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender, estrogen, and schizophrenia.
    Lindamer LA; Lohr JB; Harris MJ; Jeste DV
    Psychopharmacol Bull; 1997; 33(2):221-8. PubMed ID: 9230634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.